POU5F1 Enhances the Invasiveness of Cancer Stem-Like Cells in Lung Adenocarcinoma by Upregulation of MMP-2 Expression

Lung cancer is the leading cause of cancer-related human deaths. Exploration of the mechanisms underlying the metastasis of cancer stem-like cells (CSLCs) will open new avenues in lung cancer diagnosis and therapy. Here, we demonstrated that CSLCs-derived from lung adenocarcinoma (LAC) cells displayed highly invasive and migratory capabilities via expressing high levels of POU5F1 and MMP-2. We found that POU5F1 directly regulated MMP-2 transcription via interaction with the promoter of MMP-2. POU5F1 knockdown in LACSLCs reduced MMP-2 protein abundance, leading to inhibition of the cell invasion, migration and tumorigenesis potentials of LAC cells. Clinically, aberrantly high expressions of POU5F1 and MMP-2 were inversely correlated with the survival of LAC patients, and the double-positive POU5F1 and MMP-2 showed the worst prediction for the patient’s poor survival. These results indicate that POU5F1 can bind to the MMP-2 promoter for the degradation of surrounding extracellular matrix, and therefore promote invasive and migratory capabilities of LACSLCs. Moreover, our data implicate that the pathological detection of the double-positive expressions for POU5F1 and MMP-2 will be useful as diagnostic and prognostic biomarkers in LAC to advance anti-metastasis therapy.

[1]  Yuh-Lih Chang,et al.  Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells , 2008, PloS one.

[2]  Henry Z. Montes,et al.  TNM Classification of Malignant Tumors, 7th edition , 2010 .

[3]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[4]  D. Jeoung,et al.  The cancer/testis antigen CAGE induces MMP-2 through the activation of NF-kappaB and AP-1. , 2009, BMB reports.

[5]  M. Björklund,et al.  Gelatinase-mediated migration and invasion of cancer cells. , 2005, Biochimica et biophysica acta.

[6]  A. Lokshin,et al.  Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. , 2010, Cancer research.

[7]  X. Bian,et al.  Strategies for isolating and enriching cancer stem cells: well begun is half done. , 2013, Stem cells and development.

[8]  H. Lehrach,et al.  Analysis of Oct4‐Dependent Transcriptional Networks Regulating Self‐Renewal and Pluripotency in Human Embryonic Stem Cells , 2007, Stem cells.

[9]  D. Dinh,et al.  MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells , 2011, PloS one.

[10]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[11]  D. Weiss,et al.  Stem cells and cell therapy approaches in lung biology and diseases , 2010, Translational Research.

[12]  C. Ji,et al.  Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis , 2012, Molecular Biology Reports.

[13]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[14]  B. Wang,et al.  Connexin 43 Reverses Malignant Phenotypes of Glioma Stem Cells by Modulating E‐Cadherin , 2012, Stem cells.

[15]  Yi-xue Gu,et al.  Inhibition of growth and motility of human A549 lung carcinoma cells by a recombined vascular basement membrane derived peptide. , 2010, Cancer letters.

[16]  C. Marsden,et al.  Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action. , 2009, Methods in molecular biology.

[17]  Akihiro Inoue,et al.  Oct‐3/4 promotes migration and invasion of glioblastoma cells , 2012, Journal of cellular biochemistry.

[18]  M. Onaitis,et al.  Cell of origin of lung cancer , 2013, Journal of carcinogenesis.

[19]  J. Vilo,et al.  A Data Integration Approach to Mapping OCT4 Gene Regulatory Networks Operative in Embryonic Stem Cells and Embryonal Carcinoma Cells , 2010, PloS one.

[20]  B. Han,et al.  Prognostic significance of OCT4 expression in adenocarcinoma of the lung. , 2010, Japanese journal of clinical oncology.

[21]  Alejandra Bruna,et al.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. , 2007, Cancer cell.

[22]  Z. Werb,et al.  Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. , 2010, Cancer research.

[23]  Peng Zhang,et al.  Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway , 2012, The Journal of Immunology.

[24]  Xiaofei Xu,et al.  The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. , 2013, The international journal of biochemistry & cell biology.

[25]  H. Lehrach,et al.  Analysis of Oct 4-Dependent Transcriptional Networks Regulating Self-Renewal and Pluripotency in Human Embryonic Stem Cells , 2007 .

[26]  M. Biffoni,et al.  Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.

[27]  T. Hsia,et al.  Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. , 2012, Anticancer research.

[28]  A. Shiau,et al.  Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. , 2008, Cancer research.

[29]  Q. Wang,et al.  The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis , 2010, Cancer investigation.

[30]  You-hong Cui,et al.  β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. , 2013, Cancer research.

[31]  S. Chiou,et al.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. , 2010, Cancer research.

[32]  P. Savagner,et al.  Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion , 2013, Molecular Cancer Therapeutics.

[33]  Eric Deutsch,et al.  Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data , 2010, Journal of oncology.

[34]  J. Minna,et al.  Tumor oncogenotypes and lung cancer stem cell identity. , 2010, Cell stem cell.

[35]  Shun-Fa Yang,et al.  Matrix metalloproteinase-2 as a target for head and neck cancer therapy , 2013, Expert opinion on therapeutic targets.

[36]  X. Bian,et al.  Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.